Inbrain Neuroelectronics is a pioneering company at the forefront of neurotechnological advancements,  specializing in the development of graphene-based high precision neuro and biolectronic therapies. The company prioritizes in developing personalized therapies, mainly for Parkinson’s Disease (PD) but also in the BCI space for speech impairment.

Its end-to-end neural platform combines hardware and data analytics to decode & modulate neural networks, maximize time on therapy and effectively restore function or mobility for patients.